BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pariente G, Leibson T, Shulman T, Adams-Webber T, Barzilay E, Nulman I. Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis. CNS Drugs 2017;31:439-50. [PMID: 28434134 DOI: 10.1007/s40263-017-0433-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Kameg BN. Bipolar disorder: Treatment strategies for women of childbearing age. Perspect Psychiatr Care 2021;57:1244-9. [PMID: 33164215 DOI: 10.1111/ppc.12680] [Reference Citation Analysis]
2 Demailly R, Escolano S, Haramburu F, Tubert-Bitter P, Ahmed I. Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies. Drug Saf 2020;43:549-59. [PMID: 32124266 DOI: 10.1007/s40264-020-00916-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhu Q, Guo Y, Ma S, Yang L, Lin Z, Sun H, Li G, Yu L. Sociodemographic factors associated with the first administration of anti-seizure medication in patients with focal epilepsy in Western China. BMC Neurol 2021;21:251. [PMID: 34187396 DOI: 10.1186/s12883-021-02282-w] [Reference Citation Analysis]
4 Raffi ER, Nonacs R, Cohen LS. Safety of Psychotropic Medications During Pregnancy. Clin Perinatol 2019;46:215-34. [PMID: 31010557 DOI: 10.1016/j.clp.2019.02.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
5 Lavu A, Vaccaro C, Shouman W, Severini SA, Eltonsy S. Anti-epileptic drug exposure during pregnancy and neonatal birth weight outcomes: protocol for a systematic review and meta-analysis. Syst Rev 2021;10:159. [PMID: 34051859 DOI: 10.1186/s13643-021-01711-8] [Reference Citation Analysis]
6 Besag FMC, Vasey MJ, Sharma AN, Lam ICH. Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. Ther Adv Psychopharmacol 2021;11:20451253211045870. [PMID: 34646439 DOI: 10.1177/20451253211045870] [Reference Citation Analysis]
7 Thomson M, Sharma V. Pharmacotherapeutic considerations for the treatment of posttraumatic stress disorder during and after pregnancy. Expert Opin Pharmacother 2021;22:705-14. [PMID: 33225773 DOI: 10.1080/14656566.2020.1854727] [Reference Citation Analysis]
8 Negro A, Delaruelle Z, Ivanova TA, Khan S, Ornello R, Raffaelli B, Terrin A, Reuter U, Mitsikostas DD; European Headache Federation School of Advanced Studies (EHF-SAS). Headache and pregnancy: a systematic review. J Headache Pain 2017;18:106. [PMID: 29052046 DOI: 10.1186/s10194-017-0816-0] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 12.2] [Reference Citation Analysis]
9 Margulis AV, Hernandez-Diaz S, McElrath T, Rothman KJ, Plana E, Almqvist C, D'Onofrio BM, Oberg AS. Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth. PLoS One 2019;14:e0214180. [PMID: 31381574 DOI: 10.1371/journal.pone.0214180] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
10 Uguz F. Pharmacological prevention of mood episodes in women with bipolar disorder during the perinatal period: A systematic review of current literature. Asian J Psychiatr 2020;52:102145. [PMID: 32516746 DOI: 10.1016/j.ajp.2020.102145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Friedrich L, Sruk A, Bielen I. Women with epilepsy in childbearing age: Pregnancy-related knowledge, information sources, and antiepileptic drugs. Epilepsy & Behavior 2018;80:122-8. [DOI: 10.1016/j.yebeh.2018.01.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Trifu SC, Popescu A, Marian MA. Affective disorders: A question of continuing treatment during pregnancy (Review). Exp Ther Med 2020;20:3474-82. [PMID: 32905103 DOI: 10.3892/etm.2020.8989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Kalisch-Smith JI, Ved N, Sparrow DB. Environmental Risk Factors for Congenital Heart Disease. Cold Spring Harb Perspect Biol 2020;12:a037234. [PMID: 31548181 DOI: 10.1101/cshperspect.a037234] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
14 Dasgupta A, Krasowski MD. Antiepileptic drugs. Therapeutic Drug Monitoring Data. Elsevier; 2020. pp. 99-158. [DOI: 10.1016/b978-0-12-815849-4.00009-8] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hashimoto Y, Kotake K, Watanabe N, Fujiwara T, Sakamoto S. Lamotrigine in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev 2021;9:CD013575. [PMID: 34523118 DOI: 10.1002/14651858.CD013575.pub2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Goldstein L, Shihman B, Amiel N, Benninger F. Termination of pregnancy in women with epilepsy - A retrospective single center study. Epilepsy Behav 2018;87:89-91. [PMID: 30131224 DOI: 10.1016/j.yebeh.2018.08.005] [Reference Citation Analysis]
17 Smeralda CL, Gigli GL, Janes F, Valente M. May lamotrigine be an alternative to topiramate in the prevention of migraine with aura? Results of a retrospective study. BMJ Neurol Open 2020;2:e000059. [PMID: 33681794 DOI: 10.1136/bmjno-2020-000059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Damkier P, Christensen LS, Broe A. Patterns and predictors for prescription of psychotropics and mood-stabilizing antiepileptics during pregnancy in Denmark 2000-2016. Br J Clin Pharmacol 2018;84:2651-62. [PMID: 30079516 DOI: 10.1111/bcp.13732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Clark CT, Wisner KL. Treatment of Peripartum Bipolar Disorder. Obstet Gynecol Clin North Am 2018;45:403-17. [PMID: 30092918 DOI: 10.1016/j.ogc.2018.05.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
20 Thomson M, Sharma V. Weighing the Risks: the Management of Bipolar Disorder During Pregnancy. Curr Psychiatry Rep 2018;20:20. [PMID: 29549608 DOI: 10.1007/s11920-018-0882-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Hurault-Delarue C, Morris JK, Charlton R, Gini R, Loane M, Pierini A, Puccini A, Neville A, Snowball J, Damase-Michel C; EUROmediSAFE consortium. Prescription of antiepileptic medicines including valproate in pregnant women: A study in three European countries. Pharmacoepidemiol Drug Saf 2019;28:1510-8. [PMID: 31517430 DOI: 10.1002/pds.4897] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
22 Wang M, Li W, Tao Y, Zhao L. Emerging trends and knowledge structure of epilepsy during pregnancy research for 2000-2018: a bibliometric analysis. PeerJ 2019;7:e7115. [PMID: 31211023 DOI: 10.7717/peerj.7115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]